Cleared Traditional

K911954 - REMEDI(TM) DRUG PROFILING SYSTEM

K911954 is the FDA 510(k) clearance for REMEDI(TM) DRUG PROFILING SYSTEM by Bio-Rad. It is a Class 2 Toxicology device (product code DJR) cleared through the Traditional 510(k) pathway after a 22-day FDA review.

K911954 · Bio-Rad · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1991
Decision
22d
Days
Class 2
Risk

K911954 is an FDA 510(k) clearance for the REMEDI(TM) DRUG PROFILING SYSTEM, MODIFICATION. Classified as Enzyme Immunoassay, Methadone (product code DJR), Class II - Special Controls.

Submitted by Bio-Rad (Hercules, US). The FDA issued a Cleared decision on May 23, 1991 after a review of 22 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3620 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bio-Rad devices

Submission Details

510(k) Number K911954 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 01, 1991
Decision Date May 23, 1991
Days to Decision 22 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 87d · This submission: 22d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DJR Enzyme Immunoassay, Methadone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3620
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - DJR Enzyme Immunoassay, Methadone

All 47
Devices cleared under the same product code (DJR) and FDA review panel - the closest regulatory comparables to K911954.
METHADONE METABOLITE EIA ASSAY
K931780 · Diagnostic Reagents, Inc. · Aug 1993
IL TEST METHADONE
K920858 · Instrumentation Laboratory CO · Apr 1992
SYVA EMIT II METHADONE ASSAY
K920751 · Syva Co. · Mar 1992
TDX METHADONE ASSAY
K884968 · Abbott Laboratories · Dec 1988
REVISED LABELING FOR SYVA METHADONE ASSAYS
K873899 · Syva Co. · Oct 1987
LABELING CHANGES COAT-A-COUNT METHADONE IN URINE
K873750 · Diagnostic Products Corp. · Oct 1987